1.48
price down icon6.33%   -0.10
after-market 시간 외 거래: 1.50 0.02 +1.35%
loading
전일 마감가:
$1.58
열려 있는:
$1.57
하루 거래량:
311.56K
Relative Volume:
1.47
시가총액:
$65.70M
수익:
-
순이익/손실:
$-28.54M
주가수익비율:
-2.3125
EPS:
-0.64
순현금흐름:
$-22.72M
1주 성능:
-5.13%
1개월 성능:
-10.84%
6개월 성능:
-75.50%
1년 성능:
-81.86%
1일 변동 폭
Value
$1.43
$1.59
1주일 범위
Value
$1.43
$1.65
52주 변동 폭
Value
$1.40
$8.59

Essa Pharma Inc Stock (EPIX) Company Profile

Name
명칭
Essa Pharma Inc
Name
전화
(778) 331-0962
Name
주소
SUITE 720, VANCOUVER, BC
Name
직원
35
Name
트위터
@essapharma
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
EPIX's Discussions on Twitter

EPIX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
EPIX
Essa Pharma Inc
1.48 65.70M 0 -28.54M -22.72M -0.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-04 다운그레이드 Jefferies Buy → Hold
2024-11-04 다운그레이드 Oppenheimer Outperform → Perform
2024-11-04 다운그레이드 Piper Sandler Overweight → Neutral
2023-06-26 재개 Oppenheimer Outperform
2021-03-04 개시 Piper Sandler Overweight
2021-01-11 재확인 H.C. Wainwright Buy
2020-11-02 개시 Jefferies Buy
2019-10-25 개시 Oppenheimer Outperform
모두보기

Essa Pharma Inc 주식(EPIX)의 최신 뉴스

pulisher
Apr 01, 2025

We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance

Apr 01, 2025
pulisher
Mar 25, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider

Mar 25, 2025
pulisher
Mar 25, 2025

EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Mar 25, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire

Mar 24, 2025
pulisher
Mar 24, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus

Mar 24, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire

Mar 24, 2025
pulisher
Mar 23, 2025

Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.

Mar 23, 2025
pulisher
Mar 23, 2025

ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal

Mar 23, 2025
pulisher
Mar 22, 2025

Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire

Mar 22, 2025
pulisher
Mar 21, 2025

Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR

Mar 20, 2025
pulisher
Mar 20, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks

Mar 20, 2025
pulisher
Mar 19, 2025

EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 19, 2025
pulisher
Mar 18, 2025

EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Levi & Korsinsky Notifies Shareholders of ESSA Pharma - GlobeNewswire

Mar 18, 2025
pulisher
Mar 17, 2025

EPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - StreetInsider.com

Mar 17, 2025
pulisher
Mar 17, 2025

2025-03-17 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain OfficersEPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 16, 2025

2025-03-16 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 16, 2025
pulisher
Mar 16, 2025

EPIX Stockholders Have Opportunity to Lead ESSA Pharma Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider

Mar 16, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Mar 15, 2025
pulisher
Mar 14, 2025

Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineEPIX - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - GlobeNewswire Inc.

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

2025-03-14 | Investors who lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 14, 2025
pulisher
Mar 13, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March ... - The Bakersfield Californian

Mar 13, 2025
pulisher
Mar 13, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 25, 2025 Deadline to file Lead Plaintiff Motion - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

EPIX LAWSUIT ALERT: Levi & Korsinsky Notifies ESSA Pharma - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - PR Newswire

Mar 13, 2025
pulisher
Mar 13, 2025

March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX - PR Newswire

Mar 13, 2025
pulisher
Mar 12, 2025

EPIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 12, 2025
pulisher
Mar 12, 2025

Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing

Mar 12, 2025
pulisher
Mar 12, 2025

ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. - GlobeNewswire

Mar 12, 2025
pulisher
Mar 11, 2025

Levi & Korsinsky Notifies Shareholders of ESSA Pharma Inc. (EPIX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 11, 2025

Essa Pharma Inc (EPIX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):